EXACT Sciences Corporation (EXAS) — Cash Flow Reinvestment Rate
EXACT Sciences Corporation (EXAS) has a Cash Flow Reinvestment Rate of 1.51x as of December 2025, reinvesting $228.60 Million (capex $31.24 Million plus investments $197.36 Million) from operating cash flow of $151.69 Million. Check EXACT Sciences Corporation (EXAS) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
EXACT Sciences Corporation Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for EXACT Sciences Corporation across 4 annual periods. Explore EXAS long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for EXACT Sciences Corporation (2020–2025)
Year-by-year capital reinvestment analysis for EXACT Sciences Corporation. For live market cap and broader valuation context, see EXAS market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.04x | $511.17 Million | $491.44 Million | $134.66 Million | ▼ -62.1% |
| 2024 | 2.75x | $578.14 Million | $210.54 Million | $135.99 Million | ▲ +146.6% |
| 2023 | 1.11x | $173.87 Million | $156.12 Million | $124.19 Million | ▼ -46.4% |
| 2020 | 2.08x | $283.58 Million | $136.48 Million | $64.35 Million | — |